Latest Breaking News On - Calmette guerin - Page 1 : comparemela.com

Theralase narrows Q1 loss as it advances bladder cancer trial

Theralase narrows Q1 loss as it advances bladder cancer trial
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Arkady mandelCalmette guerinMichael jewettTheralase technologies incBacillus calmette guerinUnresponsive non muscle invasive bladder cancerCarcinoma in situStudy procedurePhoto dynamic compounds

AUA 2024: Back to Medical School: Immunology in NMIBC and Neoadjuvant MIBC for the Urologist

AUA 2024: Back to Medical School: Immunology in NMIBC and Neoadjuvant MIBC for the Urologist
urotoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urotoday.com Daily Mail and Mail on Sunday newspapers.

San antonioUnited statesCalmette guerinRobert svatekJulian chavarriagaUniversity of torontoSociety of urologic oncologyAmerican urological associationUt health san antonioUrological associationUrologic oncologyCell deathUrologic oncologistClinical fellow

Cretostimogene Monotherapy Demonstrated 75 2% Complete Response Rate in High-Risk,

- Phase 3 BOND-003 study results showed sustained, durable complete responses over 12 months with novel investigational oncolytic immunotherapy -

San antonioUnited statesAmbaw belleteLaurence wattsGaryd steinbergMarkd tysonCretostimogene grenadenorepvecCalmette guerinDrug administrationGlobe newswire cg oncology incAmerican urological associationNon muscle invasive bladder cancerBacillus calmette guerinPractice changing clinical trialsUrology plenary sessionUrologic oncologist

CG Oncology to Host Virtual Investor Event on Friday, May 3, 2024

IRVINE, Calif., April 26, 2024 (GLOBE NEWSWIRE) CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients

San antonioUnited statesCalmette guerinLaurence wattsMarkd tysonCretostimogene grenadenorepvecHenryb gonzIntravesical cretostimogene grenadenorepvecGlobe newswire cg oncology incConvention centerAmerican urological associationAnnual meetingSingle arm studyHigh riskUnresponsive non muscle invasive bladder cancerPractice changing clinical trials

CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024

CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMccormick placeCalmette guerinCretostimogene grenadenorepvecVijay kasturiRoger liMccormick place convention centerGlobe newswire cg oncology incAmerican society of clinical oncologyCg oncology incAmerican societyClinical oncologyChief medical officerNon muscle invasive bladder cancerSitu abstract numberPrimary track